The healthcare sector underwent remarkable change in the last decade due to the increased use of innovative products and therapies. The evolution of dialysis technology contributes to development of the healthcare sector. Researchers focus on innovative products and machines for dialysis. Companies producing dialysis products are investing more in R&D. Home dialysis and portable dialysis machines are gaining popularity among patients suffering from end-stage kidney disease, kidney failure and acute kidney injury.
The focus of this report is the role of drugs and medical device intervention (dialysis) in the treatment and management of Chronic Kidney Disease (CKD).
The global market for CKD drugs and dialysis devices was valued at REDACTED in 2017 and is expected to witness a growth of REDACTED CAGR to reach REDACTED by 2023.Reasons for Doing This Study
The economic impact of CKD remains a global crisis. Even with the gradual shift in treatment guidelines and innovation, nearly 10% of the U.S. population suffers from this disease that is often referred to as a silent killer. Today, one out of seven people in the U.S. have CKD. Most are unaware that they have it. Millions of patients go undiagnosed each year due to lack of treatment and affordable care. Annual treatment costs for Medicare beneficiaries with CKD are as high as $64 billion, with an additional $34 billion spent on treating patients with end stage renal disease (ESRD).
Expenditures related to kidney failure consume about 10% of the total Medicare budget, accounting for treatment of less than 1% of all Medicare recipients. The imbalance between cost and clinical outcomes associated with CKD create an impenetrable health care burden.
Kidney failure is the ninth-leading cause of death in the U.S., accounting for about 47,000 fatalities in 2013. Approximately 33 million Americans currently have CKD. Another 20 million are at increased risk for developing CKD.
More than two million people, worldwide, receive treatment: dialysis or kidney transplant. Of the subset being treated for kidney failure, the majority are treated in only five countries: the U.S., Japan, Germany, Brazil and Italy. These five countries represent only 12% of the world population. Forecasts suggest that the number of cases of kidney failure will increase disproportionately in developing countries, like China and India, where the number of elderly people is increasing.
CKD is a global health problem. This report provides a regional analysis of costs and clinical outcomes related to the management of CKD around the world. Data is further segmented by CKD stage, end user and application.
This market analysis is intended to provide analytical information to optimize business strategies. The ability to execute operating plans effectively rests on a companys ability to integrate industry research and data.
Publisher Name : BCC Research
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Background of Chronic Kidney Disease
Hospitalization for Kidney Disease
Costs of Chronic Kidney Disease
Epidemiology of Renal Disease
Cause of Chronic Kidney Disease
Pathology of Chronic Kidney Disease
Diagnostic Methods for Identification and Detection of Chronic Kidney Disease
Clinical Markers for the Detection of Chronic Kidney Disease
Treatment and Management of Chronic Kidney Disease (CKD)
Cholesterol Management Medications
Medical Device Interventions
Principles of Renal Dialysis
Function of Renal Dialysis
Types of Renal Dialysis
Additional Medications for Dialysis Patients
Medications for CKD Patients on Peritoneal Dialysis
Novel Kidney Treatment in Development
Portable, Cartridge-Based Hemodialysis Device
Wearable Peritoneal Dialysis Device
The Transplant Procedure
Waiting List for Kidney Transplantation
Economics of Kidney Transplant
Drugs Used in Conjunction with Kidney Transplantation
Immunosuppressant Agents for Kidney Transplant
Software and Mobile Applications for Chronic Kidney Disease Management
Smartphone Technology and Mobile Apps
Mobile Apps for CKD Patients
Mobile Apps for CKD Professionals
Diet and Nutrition Apps
Chapter 4 Market Overview
Factors Affecting Renal Dialysis Market
Drivers of the Renal Dialysis Market
Current Challenges for the Renal Dialysis Market
Regulations and Reimbursement Landscape
U.S. FDA 510(k) Approval
Chapter 5 Market Segment Analysis
Segment Analysis, by Treatment Intervention
Medical Device Interventions-Dialysis
Analysis of Medical Device Intervention, by Product
Analysis of Medical Device Intervention/Dialysis Market, by End User
Chapter 6 Market Breakdown by Region
Chapter 7 Patent Review/ New Developments
Patents, by Year
Patents, by Type
Patents, by Company
Patents, by Country
Patents, by Assignee
Prevention and Treatment of Chronic Kidney Disease
Use of Dynamin Ring Stabilizers
Compositions for the Treatment of Kidney Disease
Methods and Compositions in AKI
Treatment of CKD and Other Renal Dysfunction: GDF15 Modulator
Methods for Diagnosing and Assessing Kidney Disease
Treatment and Prevention of Chronic Kidney Disease
Pharmaceutical Composition for Treating Chronic Kidney Disease
Detection of Chronic Kidney Disease and Disease Progression
Methods and Composition for Diagnosis and Prognosis of Renal Injury and Renal Failure
Treatment for Chronic Kidney Disease
PromarkerD-A Predictive and Diagnostic Test for Chronic Kidney Disease
Chapter 8 Competitive Landscape
Dialysis Equipment and Accessories Manufacturers
Market Share Analysis for Dialysis
Recent Industry Developments
Key Mergers and Acquisitions
Chapter 9 Company Profiles
ABBVIE BIOTHERAPEUTICS CORP.
ACCELERON PHARMA, INC.
ACON LABORATORIES, INC.
AKEBIA THERAPEUTICS, INC.
AMERICAN REGENT, INC.
AMERICAN RENAL ASSOCIATES
ASAHI KASEI KURARAY MEDICAL CO.
ASTELLAS PHARMA U.S., INC.
AURINIA PHARMACEUTICALS, INC.
ASTUTE MEDICAL, INC.
AVEO PHARMACEUTICALS, INC.
AWAK TECHNOLOGIES, INC.
B. BRAUN MEDICAL, INC.
BARD ACCESS SYSTEMS, INC.
BAXTER INTERNATIONAL, INC.
BAYER HEALTHCARE PHARMACEUTICALS LLC
CENTERS FOR DIALYSIS CARE
CHONG KUN DANG PHARMACEUTICAL CORP.
CONCERT PHARMACEUTICALS, INC.
DIALYSIS CLINIC, INC. (DCI)
DIAMEDICA THERAPEUTICS, INC.
DIVERSIFIED SPECIALTY INSTITUTES (DSI)
ELI LILLY AND CO.
FRESENIUS MEDICAL CARE (FMC)
JANSSEN PHARMACEUTICALS, INC.
KIDNEY CENTER, INC.
KRINGLE PHARMA, INC.
MERCK & CO.
NORTHWEST KIDNEY CENTERS
NOVO NORDISK A/S
NOXXON PHARMA A/G
NXSTAGE MEDICAL, INC.
OUTSET MEDICAL, INC.
PROMETHEUS LABORATORIES, INC.
RENAL RESEARCH INSTITUTE (RRI) LLC
QUANTA FLUID SOLUTION LTD.
SATELLITE HEALTHCARE/WELLBOUND CONCERT
SHIRE PHARMACEUTICALS GROUP
U.S. RENAL CARE INC. (USRC)
VASCULAR ACCESS CENTERS
VASCULAR PHARMACEUTICALS, INC.
VIFOR PHARMA LTD.
List Of Tables
Summary Table : Global Market for Chronic Kidney Disease, by Type, Through 2023
Table 1 : Stages of Chronic Kidney Disease: A Clinical Action Plan
Table 2 : Awareness, Treatment and Measures of Control of Risk Factors, 1998-2012
Table 3 : Incidence of ESRD, by Country, 2015
Table 4 : Prevalence of ESRD, by Country, 2015
Table 5 : Incidence of ESRD Patients (Due to Diabetes), by Country, 2015
Table 6 : Kidney Transplant Rates, by Country, 2015
Table 7 : Pathologies and Etiologies Associated with CKD
Table 8 : Common Medications Associated with Chronic Kidney Disease
Table 9 : Prevalence of Hypertension and Dyslipidemia, by CKD Stage
Table 10 : Patients Share of Commonly Prescribed Medication for Chronic Kidney Disease
Table 11 : Recommended Antihypertensive Agents for Patients with Chronic Kidney Disease and Hypertension
Table 12 : Commonly Prescribed Ace Inhibitors
Table 13 : Commonly Prescribed Angiotensin Receptor Blockers
Table 14 : Commonly Prescribed Beta Blockers
Table 15 : Commonly Prescribed Calcium Channel Blockers
Table 16 : Commonly Prescribed Phosphate Binders
Table 17 : Commonly Prescribed Statins
Table 18 : Commonly Prescribed Bile Acid Sequestrants
Table 19 : Commonly Prescribed Fibrates
Table 20 : Commonly Prescribed Diuretics
Table 21 : Commonly Prescribed Erythropoiesis-Stimulating Agents
Table 22 : Commonly Prescribed Iron Supplements
Table 23 : Commonly Prescribed Glucose Management Drugs
Table 24 : Commonly Prescribed Medication for Chronic Kidney Disease
Table 25 : Commonly Prescribed Immunosuppressant Drugs
Table 26 : Immunosuppression Maintenance Regimens
Table 27 : Immunosuppression Induction Drug Therapies
Table 28 : Global Market for Chronic Kidney Disease, by Type, Through 2023
Table 29 : Reimbursement of Dialysis Services per Week, 2011-2013
Table 30 : Global Market for CKD Pharmaceutical Drugs, by Type, Through 2023
Table 31 : Global Market for CKD Stage 1-5 Drugs, by Region, Through 2023
Table 32 : Common Drug Classes Used, by Part D-Enrolled Dialysis Patients, 2013
Table 33 : Global Market for Dialysis Drugs, by Region, Through 2023
Table 34 : Global Market for Post-Transplantation Drugs, by Region, Through 2023
Table 35 : Global Market for Dialysis Devices, by Type, Through 2023
Table 36 : Global Market for Hemodialysis, by Region, Through 2023
Table 37 : Key Peritoneal Products and Manufacturers
Table 38 : Global Market for Peritoneal Dialysis, by Region, Through 2023
Table 39 : Global Market for Dialysis Devices, by Product, Through 2023
Table 40 : Global Market for Dialysis Accessories, by Region, Through 2023
Table 41 : Global Market for Dialysis Equipment, by Region, Through 2023
Table 42 : Global Market for Dialysate and Other Solutions, by Region, Through 2023
Table 43 : Global Market for Dialysis Devices, by End User, Through 2023
Table 44 : Global Market for Medical Care Centers, by Region, Through 2023
Table 45 : Global Market for In-Home Dialysis, by Region, Through 2023
Table 46 : Global Market for Chronic Kidney Disease, by Region, Through 2023
Table 47 : North American Market for Chronic Kidney Disease, by Country, Through 2023
Table 48 : European Market for Chronic Kidney Disease, by Country, Through 2023
Table 49 : Asia-Pacific Market for Chronic Kidney Disease, by Country, Through 2023
Table 50 : Rest of the World Market for Chronic Kidney Disease, by Country, Through 2023
Table 51 : Patents on Renal Dialysis Equipment and Technology, by Year, 2014-2017
Table 52 : Patents on Renal Dialysis Equipment and Technology, by Type, 2014-2017
Table 53 : Patents on Renal Dialysis Equipment and Technology, by Company, 2014-2017
Table 54 : Patents on Renal Dialysis Equipment and Technology, by Country, 2014-2017
Table 55 : Patent Shares of Renal Dialysis Equipment and Technology, 2014-2017
Table 56 : Patents on Renal Dialysis Equipment and Technology, by Assignee, 2014-2017
Table 57 : New Developments in Renal Dialysis, 2014-2017
Table 58 : Key Mergers and Acquisitions in Renal Dialysis, 2014-2017
List Of Figures
Summary Figure : Global Market for Chronic Kidney Disease, by Type, 2017-2023
Figure 1 : Patents on Renal Dialysis Equipment and Technology, by Year, 2014-2017
Figure 2 : Patents on Renal Dialysis Equipment and Technology, by Type, 2014-2017
Figure 3 : Patents on Renal Dialysis Equipment and Technology, by Assignee, 2014-2017
Figure 4 : Global Market Share of Dialysis Medical Devices, by Company, 2017
There is no reviews available for this report